Robert Wasserman
Stock Analyst at Benchmark Co.
(4.23)
# 1,500
Out of 4,646 analysts
231
Total ratings
45.7%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Downgraded: Hold | n/a | $35.06 | - | 11 | Aug 10, 2026 | |
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,444 | ILA 2,169 | +104.91% | 5 | Jul 20, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 → $335 | $293.72 | +14.05% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $166.96 | +10.80% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Maintained: Buy | $91 | $91.64 | -0.70% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.40 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $125.31 | -24.18% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $98.54 | -8.67% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Maintained: Hold | n/a | $1.57 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $3.37 | +18.69% | 11 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $3.96 | +846.97% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.40 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $4.57 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.60 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.40 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $4.80 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $590.66 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $203.04 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.09 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.50 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.93 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.54 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.46 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $1.66 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $1.32 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $2.19 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.98 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $7.32 | n/a | 1 | Mar 12, 2013 |
BioLife Solutions
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $35.06
Upside: -
Kamada Ltd.
Jul 20, 2026
Maintained: Buy
Price Target: ILA 4,444
Current: ILA 2,169
Upside: +104.91%
Ligand Pharmaceuticals
Jul 16, 2026
Maintained: Buy
Price Target: $220 → $335
Current: $293.72
Upside: +14.05%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $166.96
Upside: +10.80%
Proto Labs
Jul 6, 2026
Maintained: Buy
Price Target: $91
Current: $91.64
Upside: -0.70%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.40
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $125.31
Upside: -24.18%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $98.54
Upside: -8.67%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $1.57
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $3.37
Upside: +18.69%
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $3.96
Upside: +846.97%
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $11.40
Upside: n/a
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $4.57
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $4.60
Upside: n/a
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.40
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $4.80
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $590.66
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $203.04
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $5.09
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.50
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.93
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.54
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.46
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $1.66
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $1.32
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $2.19
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.98
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $7.32
Upside: n/a